H2020Индивидуална стипендия2020–2022

DEAllAct · Dissecting and Engineering Allosteric Activation in a Biosynthetic Enzyme

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2020-11-16 → 2022-11-15
Финансиране от ЕС
203 852 €
Участници
1
Схема
MSCA-IF

Линиите свързват координатора с партньорите.

Накратко на български

Ензимът ATPPRT от арктическа бактерия се анализира, за да се разбере как регулаторни протеини променят неговата активност при синтеза на хистидин. Това помага за създаването на компютърен инструмент за предвиждане на мутации, които да подобрят производството на хистидин в бактериите.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Dissecting and Engineering Allosteric Activation in a Biosynthetic Enzyme

Enzymes are biological catalysts that speed up the rate of a specific chemical reaction in the cell, performing important functions and supporting life. Enzymes can be allosterically modulated, i.e. altering their reaction rate and/or substrate affinity upon binding to or mutation of a site remote from the active site of the enzyme. These processes are fundamental regulatory mechanisms of biochemical reactions that often involve a complex network of interactions. The enzyme ATP phosphoribosyltransferase (ATPPRT) from the cold-adapted bacterium Psychrobacter arcticus, is responsible for the first and flux-controlling step in histidine biosynthesis and is subject to complex allosteric control. ATPPRT is constituted of two parts, the protein possessing the catalytic domains (HisGs) and a catalytically inactive regulatory (HisZ). HisZ has a dual function: it allosterically enhances catalysis by HisGs, and it binds histidine and mediates allosteric inhibition, making it a model system for understanding the allosteric regulation of catalysis. Overcoming histidine inhibition in ATPPRT is key in synthetic biology efforts toward histidine production in bacteria. The DEAllAct project aimed to understand the molecular details of the catalytic and allosteric mechanism of ATPPRT enzyme to predict and test mutations at the protein-protein interface that enhance the catalytic activity of the protein containing the catalytic domains (HisGs) without the regulatory domain (HisZ) by mimicking its allosteric activation. The project also aimed to explore the design of a computational tool to dissect allostery by combining computational simulations and biophysical experimental studies that can be used to predict specific mutations at the protein-protein interface of allosterically regulated complexes. Conclusions of the action: 1. Successful identification of interaction networks that lead to allosteric activation of HisGs upon binding to the regulatory protein. 2. Demonstrated the involvement of two key residues at the binding domain that can rescue each other for the catalytic activation of the enzyme upon binding of the regulatory protein. 3. Developed a tool capable of identifying residues of key importance for binding interactions between the enzyme and its regulatory protein. 4. Identified and computationally validated 5 hotspots at the binding interface of HisGs that can potentially enhance its stand-alone activity.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Allosteric regulation of enzyme catalysis is widespread in nature and presents challenges and opportunities in synthetic biology. The enzyme ATP-phosphoribosyltransferase (ATPPRT) catalyses the first step in histidine biosynthesis, and is subject to complex allosteric inhibition by histidine. The short form of the enzyme, HisGS, is found in complex with a regulatory protein, HisZ. Such regulatory protein has a dual function: it allosterically enhances catalysis by HisGS, and it binds histidine and therefore mediates allosteric inhibition. The scientific aim of ""DEAllAct"" is to explore the design of a computational framework by combining state-of-the-art EVB/MM computational simulations and biophysical experimental studies to discover specific mutations at the protein-protein interface between HisGS and HisZ, that directly impact the transmission mechanism of the allosteric regulation. The fellow, Marina Corbella will carry out the project in Uppsala University under the supervision of Prof. Lynn Kamerlin who has extensive experience in computational chemistry and enzyme evolution. The first goal of ""DEAllAct"" is to elucidate the molecular details of the catalytic process of HisGS in the absence/presence of the regulatory protein HisZ via molecular dynamics simulations. Based on the information extracted from these simulations, a novel simulation tool will be developed to predict residues of key importance for binding interactions between the enzyme and the regulatory protein. Finally, the fellow will undergo a secondment at the University of St Andrews to test the hypothesis experimentally by introducing gain-of-function mutations on HisGS at the protein-protein interface to mimic the allosteric activation. Altogether, ""DEAllAct"" will provide the fellow with a highly competitive multidisciplinary profile by complementing her previous acquired expertise, putting her in a strong position to initiate her career as an independent and innovative research leader.""

Оригинален текст от CORDIS (на английски).

Участници

  • UPPSALA UNIVERSITET · UppsalaКоординаторШвеция

Връзки

Данни: CORDIS, © Европейски съюз